Obesity Care and GLP-1 Medicines: A Practical Update

1. Program overview

The first global guideline on GLP-1 medicines for obesity was issued in December 2025, and explicitly cited health-system unpreparedness as a limitation. This course addresses that gap. It covers obesity as a chronic disease rather than a lifestyle failure, assessment and comorbidity screening, where GLP-1 receptor agonists fit alongside nutrition and behavioural support, dosing escalation and adverse effect management, monitoring, the questions patients actually ask, and the equity and supply issues. Particularly relevant in regions with high metabolic disease prevalence.

2. Why this program

• Reflects the 2025 global guideline.
• Obesity framed as a chronic disease.
• Adverse effect management taught practically.
• Addresses the questions patients actually ask.

3. Who it is for

Physician · Nurse · Pharmacist · Nutritionist · Allied Health

4. Program objectives

• Describe obesity as a chronic relapsing disease with metabolic drivers
• Assess a patient for obesity-related comorbidity
• Explain where GLP-1 receptor agonists fit within a care pathway
• Apply dose escalation and manage common adverse effects
• Monitor treatment response and recognise when to reassess
• Respond to common patient questions and expectations

5. Learning outcomes

• Assess a described patient for obesity-related comorbidity
• Identify appropriate candidates for GLP-1 therapy from clinical criteria
• Apply a dose escalation approach to a described case
• Manage a described adverse effect appropriately
• Evaluate treatment response against expected trajectory
• Recommend nutritional and behavioural support alongside pharmacotherapy

6. Curriculum

1. Module 1: Obesity as Chronic Disease

   • Obesity as Chronic Disease

2. Module 2: Assessment and Comorbidity

   • Assessment and Comorbidity

3. Module 3: Where GLP-1 Medicines Fit

   • Where GLP-1 Medicines Fit

4. Module 4: Dosing and Adverse Effects

   • Dosing and Adverse Effects

5. Module 5: Monitoring, Nutrition and Expectations

   • Monitoring, Nutrition and Expectations

7. Duration and structure

Total study hours: 3 — 2.5h content + 0.5h assessment. Duration is expressed in study hours only.

9. What you receive

This certificate confirms completion of Obesity Care and GLP-1 Medicines: A Practical Update. Duration is expressed in study hours.

10. Delivery format

Self-paced · start any time · any device · lifetime access to the enrolled version.